metalloprotease inhibitor (Glycomed)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namemetalloprotease inhibitor (Glycomed)
Drug Alias Nameendothelin converting enzyme inhibitor (Glycomed)ECE inhibitor (Glycomed)
ClassificationSmall molecules > Peptidomimetic
Mechanisms of ActionMatrix metalloproteinase inhibitorsEndothelin-converting enzymes inhibitors
TargetsMatrix metalloproteinaseEndothelin-converting enzymes
Therapy Area/IndicationsUlcerPsoriasisCardiovascular Diseases +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlycomed Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlycomed Inc
Active IndicationsN/A
Inactive IndicationsUlcerPsoriasisCardiovascular Diseases +[7] 

Other Information

ATC CodeN/A
Related LinksN/A